![Paolo Tarantino: Important update of the ABC trials](https://oncodaily.com/pub/uploads/2023/11/download-22-e1701200451814.jpg)
Photo of Paolo Tarantino from X
Feb 12, 2024, 15:36
Paolo Tarantino: Important update of the ABC trials
Paolo Tarantino, Medical Oncologist, Research Fellow at Dana-Farber Cancer Institute, shared a post on X/Twitter:
“Important update of the ABC trials.
With 6.9y of follow up, adjuvant AC-T had a small RFI benefit over TC, restricted to triple-negative tumors.
No OS benefit by adding anthracyclines, but a major increase in leukemias (7 vs 1) & non-BC deaths (62 vs 34).
https://ascopubs.org/doi/10.1200/JCO.23.01428 “
Source: Paolo Tarantino / X
Jul 26, 2024, 00:27